UThymoKidney

Revivicor Breaks Ground in Xenotransplantation, Achieving Two Months of Stable Function in a Genetically Engineered Kidney

Revivicor Breaks Ground in Xenotransplantation, Achieving Two Months of Stable Function in a Genetically Engineered Kidney

Anika Sharma

Revivicor, a division of United Therapeutics, has unveiled a groundbreaking advancement in organ manufacturing technology, using genetically engineered tissues from ...